Company Amexdrug Corporation Other OTC
Equities
AXRX
US0311392072
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
Pharmaceuticals
100.0
%
| 4 | 100.0 % | - |
Sales per region
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jack Amin
CEO | Chief Executive Officer | 64 | 00-03-31 |
Robert Wilkinson
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Amin
CEO | Chief Executive Officer | 64 | 00-03-31 |
Behrooz Meimand
BRD | Director/Board Member | 74 | 01-11-30 |
Rodney Barron
BRD | Director/Board Member | 70 | 01-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,409,620 | 14,225,580 ( 8.397 %) | 0 | 8.397 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.88% | 24.09B | |
+7.11% | 8.2B | |
-20.55% | 7.97B | |
-1.96% | 7.84B | |
+2.26% | 4.66B | |
+17.12% | 4.32B | |
+1.41% | 4.19B | |
-3.02% | 3.89B | |
+21.42% | 3.62B |